Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 60/100

BD to Present at Wells Fargo 2024 Healthcare Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo...

Key Takeaway: BD (Becton, Dickinson and Company) will present at the Wells Fargo 2024 Healthcare Conference on September 4, 2024. The presentation will be accessible via a live webcast from the BD investor relations website, with a replay available afterward. BD is a leading global medical technology firm focused on improving healthcare through innovative solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is participating in a major healthcare conference, showcasing its proactive engagement with industry stakeholders.
  • The company has a strong commitment to advancing global health through innovative technology and solutions.
  • BD is recognized as one of the largest global medical technology companies, indicating strong market positioning.

Full Press Release Details

FRANKLIN LAKES, N.J. , Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024 at 8:45 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD , please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When is BD's presentation at the Wells Fargo Healthcare Conference?

BD will present on September 4, 2024, at 8:45 am Eastern Time.

How can I access BD's presentation webcast?

You can access the live webcast from BD's investor relations website.

Will there be a replay of BD's presentation available?

Yes, a replay will be available on the investor relations website after the event.

What does BD aim to improve in healthcare?

BD focuses on enhancing medical discovery, diagnostics, and care delivery.

How many employees does BD have worldwide?

BD employs over 70,000 people globally.

Last updated: Aug 8, 2024